NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
16.49
-0.31 (-1.85%)
Jun 20, 2025, 11:49 AM - Market open
NovoCure Employees
NovoCure had 1,488 employees as of December 31, 2024. The number of employees increased by 35 or 2.41% compared to the previous year.
Employees
1,488
Change (1Y)
35
Growth (1Y)
2.41%
Revenue / Employee
$417,817
Profits / Employee
-$110,340
Market Cap
1.84B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
NVCR News
- 17 days ago - NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - Benzinga
- 19 days ago - Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Business Wire
- 20 days ago - Results From the Phase 3 PANOVA-3 Trial of Novocure's Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Business Wire
- 24 days ago - Novocure Announces Upcoming Investor Events - Business Wire
- 27 days ago - NovoCure: Loading Up On Growth Catalysts - Seeking Alpha
- 2 months ago - NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025 - Benzinga
- 2 months ago - NovoCure Limited (NVCR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Novocure Reports First Quarter 2025 Financial Results - Business Wire